NasdaqGS - Nasdaq Real Time Price USD
Innate Pharma S.A. (IPHA)
1.9955
+0.0955
+(5.03%)
At close: April 23 at 4:00:00 PM EDT
2.0200
+0.05
+(2.54%)
Pre-Market: 6:40:47 AM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-32,558
-32,558
-19,155
-58,457
-51,767
Investing Cash Flow
20,631
20,631
1,877
-917
-13,370
Financing Cash Flow
-1,966
-1,966
-1,828
26,819
-1,177
End Cash Position
70,605
70,605
84,225
103,756
136,792
Capital Expenditure
-2,351
-2,351
-1,122
-1,330
-11,282
Issuance of Debt
--
--
--
28,700
1,360
Repayment of Debt
-2,361
-2,361
-2,026
-2,069
-2,245
Free Cash Flow
-34,909
-34,909
-20,277
-59,787
-63,049
12/31/2020 - 10/17/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NBTX Nanobiotix S.A.
3.2941
-0.48%
NRIX Nurix Therapeutics, Inc.
11.61
+1.31%
BCTXW BriaCell Therapeutics Corp.
0.1499
+16.20%
CASI CASI Pharmaceuticals, Inc.
2.0000
+3.09%
RNTX Rein Therapeutics Inc.
1.8600
+0.54%
GTBP GT Biopharma, Inc.
2.2300
+2.29%
GON.F Geron Corporation
1.2050
-2.67%
5NRA.MU Nanobiotix SA
2.9600
0.00%
AFMD Affimed N.V.
0.7703
+4.24%
QUIA.ST Quia Pharma AB (publ)
0.0109
-3.54%